A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Clinical trial NCT06983743 · RECRUITING

Trial details

NCT number: NCT06983743
Sponsor: Erasca, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Solid Tumors

Start date: 2025-06-05
Primary completion: 2028-05-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.